Bioactive glasses represent a transformative class of biomaterials that actively participate in the biological healing process rather than serving as inert space fillers. Since the discovery of the first bioactive glass (45S5) by Larry Hench in 1969, these silica-based materials have evolved into clinically proven solutions for bone and dental tissue regeneration. Their ability to bond firmly with living tissues, stimulate osteogenesis, and even combat infection makes them indispensable in modern orthopedics and dentistry. This article provides a comprehensive, evidence-based review of bioactive glasses—their composition, mechanisms of action, clinical applications, advantages, limitations, and the future trajectory of this dynamic field.

What Are Bioactive Glasses?

Bioactive glasses are amorphous silicate materials that contain specific oxides such as silicon dioxide (SiO2), calcium oxide (CaO), sodium oxide (Na2O), and phosphorus pentoxide (P2O5). The most well-known composition, 45S5 (often called Bioglass®), consists of 45 wt% SiO2, 24.5 wt% CaO, 24.5 wt% Na2O, and 6 wt% P2O5. When this glass is exposed to physiological fluids, a series of surface reactions leads to the formation of a hydroxycarbonate apatite (HCA) layer that is chemically and structurally similar to bone mineral. This HCA layer provides the platform for strong interfacial bonding with hard and soft tissues.

Other prominent compositions include S53P4 (used in products such as BonAlive®), which has a slightly higher silica content and lower sodium content, and borate-based glasses that degrade faster and can be tailored for specific release profiles. The versatility of the glass system allows for adjustments in degradation rate, ion release, and mechanical properties by varying the oxide ratios or introducing trace elements like strontium, magnesium, or silver.

The discovery by Hench was serendipitous: during a bus ride, he conceived the idea that a material could form a bond with bone if it released ions that would precipitate a calcium phosphate layer. The resulting 45S5 composition proved successful in forming a direct, stable bond with bone without fibrous encapsulation. That foundational work spurred decades of research and clinical translation.

Mechanism of Bioactivity

The bioactivity of these glasses arises from a well-characterized sequence of surface events. Upon implantation, the glass rapidly exchanges Na+ with H+ and H3O+ from the surrounding body fluid, increasing the local pH. This alkaline environment accelerates the hydrolysis of Si–O–Si bonds, releasing soluble silica (Si(OH)4) and leaving a silica-rich gel layer on the glass surface. Calcium and phosphate ions from the glass and from the fluid then migrate into this gel, forming an amorphous calcium phosphate (CaP) layer. Over the next few days to weeks, the CaP layer crystallizes into hydroxycarbonate apatite—the mineral phase of natural bone.

This HCA layer is the critical interface. Osteoprogenitor cells attach, proliferate, and differentiate on this bioactive surface, secreting collagen matrix that subsequently mineralizes. The dissolution ions (notably Si and Ca) also exert direct osteoinductive effects by upregulating osteoblast-related genes and stimulating growth factors such as vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2). This dual mechanism—surface-mediated bonding and ionic signaling—is what differentiates bioactive glasses from other bioceramics like hydroxyapatite.

Additionally, the release of sodium and calcium ions causes a transient increase in pH that provides antibacterial activity, particularly against common pathogens such as Staphylococcus aureus and Escherichia coli. This property is especially valuable in revision surgeries or contaminated bone defects.

Applications in Orthopedics

Bioactive glasses have been used clinically for over three decades in orthopedic surgery. Their primary application is as bone graft substitutes for filling defects caused by trauma, tumor resection, infection, or congenital anomalies. They are also used as coatings on metallic implants and as scaffolds for tissue engineering.

Bone Graft Substitutes

Granulated or putty forms of bioactive glass (e.g., NovaBone®, BonAlive®) are hand-packed into bone voids. These materials are osteoconductive—meaning they serve as a scaffold for new bone growth—and also osteostimulative due to their ionic release. A meta-analysis of clinical studies showed that bioactive glass grafts achieve comparable or superior fusion rates compared to autograft in spinal fusion surgeries, with the added benefit of eliminating donor-site morbidity.

In long bone fractures with segmental defects, bioactive glass granules provide a space‐filling matrix that gradually resorbs over 6–12 months as new bone remodels. The degradation rate can be tailored through composition; for instance, borate-based glasses resorb faster than silicate glasses, making them suitable for defects where rapid revascularization is desired.

Coatings on Implants

Bioactive glass coatings applied to titanium alloy hip stems or knee components improve osseointegration—the direct structural and functional connection between living bone and the implant surface. Thermal spray techniques (plasma spraying, flame spraying) or sol-gel methods deposit a thin layer of glass that bonds chemically to both metal and bone. Clinical follow-up studies indicate that coated implants have significantly lower rates of aseptic loosening compared to uncoated counterparts, especially in patients with poor bone quality or compromised healing.

Scaffolds for Bone Tissue Engineering

Advanced manufacturing techniques such as 3D printing and robocasting have enabled the fabrication of porous bioactive glass scaffolds with controlled architecture. These scaffolds mimic trabecular bone structure, with interconnected pores ranging from 200–500 µm to allow cell infiltration and vascularization. While still largely in the preclinical and early clinical phase, such scaffolds hold promise for treating critical-sized defects. For example, a recent clinical trial for mandibular reconstruction using custom 3D-printed bioactive glass implants showed favorable outcomes in both functional and aesthetic restoration (link to study).

Applications in Dentistry

In dentistry, bioactive glasses have found roles in restorative, endodontic, and periodontal therapies. Their ability to release calcium and phosphate ions in a sustained manner promotes remineralization and tissue regeneration within the oral environment.

Restorative Dentistry and Remineralization

Bioactive glass particles are incorporated into dental composites, glass ionomer cements, and prophylactic pastes. When placed in a tooth cavity, these fillers slowly leach ions that raise the local pH and precipitate apatite, helping to seal the dentin–restoration interface and reduce secondary caries. Products such as BioMin F and Sylvania contain bioactive glass specifically engineered for remineralizing enamel and dentin. Clinical studies report up to a 30% reduction in dentin hypersensitivity after regular use of bioactive glass toothpaste, as the particles occlude open dentinal tubules with a calcium phosphate layer.

Moreover, bioactive glass components in composite restorations have been shown to release fluoride (when fluoride is included) in a pH-responsive manner—releasing more at lower pH, which is precisely when cariogenic bacteria are most active. This “smart” release behaviour provides sustained anticariogenic protection.

Endodontics

In root canal treatments, bioactive glass sealers (e.g., BioRoot™ RCS) are used as root-end filling materials and sealer cements. These materials form a strong bond with dentin, exhibit excellent sealing ability, and release calcium ions that stimulate the formation of reparative dentin. Their high pH kills residual bacteria in the root canal system, lowering the risk of post-treatment infection. Long-term follow-up indicates that bioactive glass-based sealers achieve comparable or higher success rates than traditional materials like mineral trioxide aggregate (MTA).

Periodontal Tissue Regeneration

Bioactive glass granules (e.g., Perioglas®) are used to fill periodontal bone defects and regenerate the attachment apparatus. They provide a scaffold for osteoblasts, cementoblasts, and periodontal ligament fibroblasts. The glass resorbs over time, leaving behind newly formed bone, cementum, and Sharpey’s fibers. A 5‑year randomized controlled trial demonstrated that bioactive glass treatment for intrabony defects resulted in significantly greater clinical attachment gain compared to open flap debridement alone.

Challenges and Limitations

Despite their remarkable bioactivity, bioactive glasses have limitations. The primary drawback is their brittleness—traditional silicate glasses have low fracture toughness and cannot be used in load-bearing applications without reinforcement. This has led to the development of glass-ceramics (e.g., apatite-wollastonite glass-ceramics) and composites with polymers or metals to improve mechanical resilience.

Processing difficulties also arise. Sintering bioactive glass particles into porous scaffolds requires careful control of temperature and time to avoid crystallization, which can reduce bioactivity. Additives such as porogens must be removed without damaging the glass structure.

Another challenge is the variability in degradation and ion release rates. While tailorable, predicting the in vivo behavior remains complex because local pH, fluid flow, and cellular activity differ from patient to patient. Excessive or too-rapid release of ions can lead to local toxicity or inflammation. For example, high sodium release may cause tissue necrosis in confined spaces.

Finally, regulatory approval for new formulations is stringent given the material’s interaction with living tissues. Clinical translation from the bench to bedside often takes more than a decade, limiting the pace of innovation.

Future Directions

The field of bioactive glasses is advancing on multiple fronts. Borate and borosilicate glasses offer accelerated degradation and the ability to release therapeutic ions such as copper, zinc, or strontium for antibacterial or osteogenic effects. Drug delivery systems using mesoporous bioactive glass nanoparticles (MBNs) can load antibiotics, anti-inflammatories, or growth factors for localized, sustained release. For instance, MBNs loaded with gentamicin have shown efficacy in treating bone infections in animal models.

Additive manufacturing continues to enable patient-specific scaffolds. Fused deposition, binder jetting, and stereolithography are all being explored to produce bioactive glass implants that match the anatomy of a patient’s bone defect. In situ gelling formulations, where a liquid glass precursor is injected and solidifies at body temperature, are under investigation for minimally invasive applications.

Combining bioactive glasses with biologics (such as BMPs or stem cells) represents a frontier in tissue engineering. The glass serves as both a scaffold and a biochemical cue, while the biologics provide additional regenerative signaling. Early clinical trials for spinal fusion using a bioactive glass scaffold soaked with autologous bone marrow aspirate show promising results with reduced need for iliac crest bone graft.

Finally, bioactive glasses are being considered for soft tissue regeneration, including wound healing and cartilage repair. Certain compositions can stimulate angiogenesis (blood vessel formation) and dermal fibroblast activity, suggesting they may one day play a role beyond hard tissue.

Conclusion

Bioactive glasses have matured from an experimental curiosity to a validated class of biomaterials with widespread clinical use in orthopedics and dentistry. Their ability to form a direct bond with tissue, release osteogenic ions, and even fight infection sets them apart from conventional inert implants. As manufacturing techniques improve and new compositions emerge—personalized via 3D printing or functionalized with drug payloads—the potential impact of bioactive glasses will only grow. Clinicians and researchers alike should continue to monitor this rapidly evolving field, as it holds the key to more effective, less invasive strategies for restoring both form and function in damaged bone and dental tissues.